Rifampin
Products in Health Canada’s databases that list Rifampin as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 6
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 14
- Products in all
- 6
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| ROFACT (300 MG) | 00343617 | Marketed | Bausch Health, Canada Inc. | |
| ROFACT (150 MG) | 00393444 | Marketed | Bausch Health, Canada Inc. | |
| RIFADIN (150 MG) | 02091887 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | |
| RIFADIN (300 MG) | 02092808 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | |
| RIFADIN CAP 300MG (300 MG) | 00580384 | Cancelled Post Market | Merrell Dow Pharmaceuticals (Canada) Inc., Division Of Mmdc | |
| RIFATER (120 MG) | 02148625 | Cancelled Post Market | Sanofi-Aventis Canada Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ROFACTNovember 18, 2025 · NOC 36400
- ROFACTDecember 18, 2020 · NOC 24826
- RIFADINDecember 11, 2020 · NOC 24787
- ROFACTMarch 5, 2020 · NOC 23294
- ROFACTJuly 2, 2019 · NOC 22355
- RIFATERJanuary 15, 2013 · NOC 14024
- RIFATERSeptember 24, 2008 · NOC 9797
- RIFADINMay 30, 2006 · NOC 7989
- RIFATERMay 30, 2006 · NOC 7990
- ROFACTSeptember 14, 2004 · NOC 5354
- RIFATERSeptember 27, 2000 · NOC 1439
- RIFADINSeptember 14, 2000 · NOC 1441
- RIFATERJuly 4, 1996 · NOC 4642
- RIFATERJanuary 12, 1995 · NOC 5232